Trials / Completed
CompletedNCT06878183
A New Risk Score for the Emergency Department in Patients With Upper Gastrointestinal Bleeding
Comparison of the New Risk Score (ABL Score) With the Glasgow Blatchford Score, AIMS65, and Pre-Endoscopic Rockall Score in Patients With Upper Gastrointestinal Bleeding Admitted to the Emergency Department
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 589 (actual)
- Sponsor
- Sakarya University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Abstract Background: The aim of this study was to develop a simpler, more practical, and highly effective risk scoring system for patients presenting to the emergency department with upper gastrointestinal bleeding. Methods: This single-center retrospective observational study was conducted by reviewing data from patients aged 18 years and older who presented to the Emergency Medicine Clinic of Sakarya Training and Research Hospital with symptoms and signs of upper gastrointestinal bleeding between January, 2022 to June, 2023. Patients were divided into six groups for analysis. Patients included in the transfusion, intervention, intense care unit, readmission or mortality groups were classified as high risk. Using the obtained data, a new scoring system was developed, and its effectiveness in predicting high risk and all subgroups was compared with the Glasgow Blatchford Score, AIMS65, and pre-endoscopic Rockall Score.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Routine laboratory tests of the patients were examined (such as hemogram, biochemistry, bleeding parameters). | Data obtained from routine examinations, laboratory tests and hospital reports were evaluated. |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
- First posted
- 2025-03-14
- Last updated
- 2025-03-14
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06878183. Inclusion in this directory is not an endorsement.